• Issue

    Liver International: Volume 34, Issue 5

    649-817
    May 2014
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Editorials

Free Access

Ammonia: more than a neurotoxin?

Christopher F. Rose, 
  • Pages: 649-651
  • First Published: 08 April 2014
Free Access

Does balanced haemostasis equate to normal coagulation in patients with acute liver failure?

Alex Gatt,  Pratima Chowdary, 
  • Pages: 652-654
  • First Published: 01 February 2014

Review Articles

Free Access

Beta-blockers in portal hypertension: new developments and controversies

Dhiraj Tripathi,  Peter C. Hayes, 
  • Pages: 655-667
  • First Published: 17 October 2013
Free Access

Treatment of chronic hepatitis C virus infection in the United States: some remaining obstacles

Gloria Searson,  Ellen S. Engelson,  Damaris Carriero,  Donald P. Kotler, 
  • Pages: 668-671
  • First Published: 13 January 2014

Cirrhosis and Liver Failure

Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation

Mohamed Habib,  Lara N. Roberts,  Raj K. Patel,  Julia Wendon,  William Bernal,  Roopen Arya, 
  • Pages: 672-678
  • First Published: 27 October 2013

Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis

Yoshihiro Aiba,  Kenichi Harada,  Atsumasa Komori,  Masahiro Ito,  Shinji Shimoda,  Hitomi Nakamura,  Shinya Nagaoka,  Seigo Abiru,  Kiyoshi Migita,  Hiromi Ishibashi,  Yasuni Nakanuma,  Nao Nishida,  Minae Kawashima,  Katsushi Tokunaga,  Hiroshi Yatsuhashi,  Minoru Nakamura, 
  • Pages: 679-688
  • First Published: 02 August 2013

Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure

Jesús Quintero,  Mar Miserachs,  Juan Ortega,  Javier Bueno,  Cristina Dopazo,  Itxarone Bilbao,  Lluis Castells,  Ramon Charco, 
  • Pages: 689-694
  • First Published: 08 August 2013

Risk factor of community-onset spontaneous bacterial peritonitis caused by fluoroquinolone-resistant Escherichia coli in patients with cirrhosis

Jungok Kim,  Cheol-In Kang,  Eun-Jeong Joo,  Young Eun Ha,  Sun Young Cho,  Geum-Youn Gwak,  Doo Ryeon Chung,  Kyong Ran Peck,  Jae-Hoon Song, 
  • Pages: 695-699
  • First Published: 05 November 2013
Open Access

Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients

Satoko Ohfuji,  Wakaba Fukushima,  Yachiyo Sasaki,  Akihiro Tamori,  Osamu Kurai,  Kiyohide Kioka,  Kazuhiro Maeda,  Akiko Maeda,  Yoshio Hirota, 
  • Pages: 700-706
  • First Published: 02 August 2013

Viral Hepatitis

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

Michael P. Manns,  Jonathan McCone Jr.,  Mitchell N. Davis,  Lorenzo Rossaro,  Eugene Schiff,  Mitchel L. Shiffman,  Bruce Bacon,  Marc Bourliere,  Mark S. Sulkowski,  Savino Bruno,  Luis Balart,  Jean-Pierre Bronowicki,  Paul Kwo,  Fred Poordad,  Franco Felizarta,  K. Rajender Reddy,  Frans A. Helmond,  Heather L. Sings,  Lisa D. Pedicone,  Margaret Burroughs,  Clifford A. Brass,  Janice K. Albrecht,  John M. Vierling, 
  • Pages: 707-719
  • First Published: 02 August 2013

Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models

Mohamed A. Chinnaratha,  Gary P. Jeffrey,  Gerry MacQuillan,  Enrico Rossi,  Bastiaan W. de Boer,  David J. Speers,  Leon A. Adams, 
  • Pages: 720-727
  • First Published: 12 August 2013

Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk

Yifang Han,  Rui Pu,  Xue Han,  Jun Zhao,  Weiping Li,  Jianhua Yin,  Yuwei Zhang,  Qiuxia Shen,  Jiaxin Xie,  Qi Zhang,  Shuang Jiang,  Juhong Li,  Hongwei Zhang,  Hongyang Wang,  Guangwen Cao, 
  • Pages: 728-736
  • First Published: 05 September 2013

Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy – a pilot randomised clinical trial

David A. Sheridan,  Simon H. Bridge,  Mary M. E. Crossey,  Daniel J. Felmlee,  Fiona I. Fenwick,  Howard C. Thomas,  R. Dermot G. Neely,  Simon D. Taylor-Robinson,  Margaret F. Bassendine, 
  • Pages: 737-747
  • First Published: 11 September 2013

Liver Pathobiology

Hyperammonaemia induces hepatic injury with alteration of gene expression profiles

Bin Jia,  Zu-Jiang Yu,  Zhen-Feng Duan,  Xin-Quan Lü,  Jing-Jing Li,  Xiao-Rui Liu,  Ran Sun,  Xiao-Juan Gao,  Yan-Fang Wang,  Jing-Ya Yan,  Quan-Cheng Kan, 
  • Pages: 748-758
  • First Published: 17 October 2013

Metabolite profiling and pathway analysis of acute hepatitis rats by UPLC-ESI MS combined with pattern recognition methods

Xijun Wang,  Haitao Lv,  Aihua Zhang,  Wenjun Sun,  Lian Liu,  Ping Wang,  Zeming Wu,  Dixin Zou,  Hui Sun, 
  • Pages: 759-770
  • First Published: 02 August 2013

Metabolic and Steatohepatitis

Taurine-induced insulin signalling improvement of obese malnourished mice is associated with redox balance and protein phosphatases activity modulation

Ana P. Cappelli,  Claudio C. Zoppi,  Helena C. Barbosa-Sampaio,  José M. Costa -Jr.,  André O. Protzek,  Priscila N. Morato,  Antonio C. Boschero,  Everardo M. Carneiro, 
  • Pages: 771-783
  • First Published: 31 July 2013

Liver Cancer

Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma

Kyung Hwan Kim,  Mi Sun Kim,  Jee Suk Chang,  Kwang-Hyub Han,  Do Young Kim,  Jinsil Seong, 
  • Pages: 784-794
  • First Published: 14 December 2013

The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma

Ju-Yeon Cho,  Yong-Han Paik,  Hee Chul Park,  Jeong Il Yu,  Won Sohn,  Geum-Youn Gwak,  Moon Seok Choi,  Joon Hyeok Lee,  Kwang Cheol Koh,  Seung Woon Paik,  Byung Chul Yoo, 
  • Pages: 795-801
  • First Published: 18 December 2013

Postoperative recurrence pattern and prognosis of patients with hepatocellular carcinoma, with particular reference to the hepatitis viral infection status

Shigetoshi Naito,  Hiroshi Imamura,  Akira Tukada,  Yutaka Matsuyama,  Jiro Yoshimoto,  Hiroyuki Sugo,  Yoichi Ishizaki,  Seiji Kawasaki, 
  • Pages: 802-813
  • First Published: 18 December 2013

Liver International Images

Giant hyperplasia of the caudate lobe in a non-cirrhotic patient accompanied by hepatocellular carcinoma in right lobe

Dong Jin Kim,  Wook Kim,  Kwang Yeol Paik, 
  • Page: 814
  • First Published: 11 September 2013

Letters to the Editor

Skewing KC phenotypic polarization into M2 via the intervention of oxidized LDL as potential therapeutic implications for NASH

Dexi Zhou,  Lingna Kong,  Qun Zhou,  Jun Li, 
  • Pages: 815-816
  • First Published: 25 November 2013

Green sweat: an atypical finding in drug-induced liver disease

Janaína L. Narciso-Schiavon,  Gabriella Di Giunta,  Mariana H. André,  Oscar C. Dimatos,  Esther B. Dantas-Corrêa,  Daniel H. Nunes,  Leonardo L. Schiavon, 
  • Pages: 816-817
  • First Published: 24 December 2013